EKF Diagnostics (LON:EKF) Shares Cross Above 200 Day Moving Average of $28.40

Shares of EKF Diagnostics Holdings plc (LON:EKF) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 28.40 ($0.35) and traded as high as GBX 28.43 ($0.35). EKF Diagnostics shares last traded at GBX 27.25 ($0.34), with a volume of 102,579 shares changing hands.

EKF Diagnostics Trading Down 1.1 %

The stock has a market capitalization of £123.64 million, a price-to-earnings ratio of 2,725.00 and a beta of 0.58. The company has a debt-to-equity ratio of 6.01, a current ratio of 2.69 and a quick ratio of 1.77. The business’s 50-day simple moving average is GBX 27.45 and its two-hundred day simple moving average is GBX 28.40.

Insider Buying and Selling at EKF Diagnostics

In other EKF Diagnostics news, insider Christopher H. B. Mills purchased 100,000 shares of EKF Diagnostics stock in a transaction on Friday, March 22nd. The shares were purchased at an average cost of GBX 26 ($0.32) per share, with a total value of £26,000 ($32,366.49). 5.11% of the stock is currently owned by corporate insiders.

EKF Diagnostics Company Profile

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.